Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.04
- Piotroski Score 3.00
- Grade Buy
- Symbol (ABSI)
- Company Absci Corporation
- Price $3.01
- Changes Percentage (-4.14%)
- Change -$0.13
- Day Low $2.95
- Day High $3.20
- Year High $6.72
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/12/2024
- Fiscal Year End N/A
- Average Stock Price Target $6.00
- High Stock Price Target $6.00
- Low Stock Price Target $6.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.16
- Trailing P/E Ratio -3.78
- Forward P/E Ratio -3.78
- P/E Growth -3.78
- Net Income $-110,566,000
Income Statement
Quarterly
Annual
Latest News of ABSI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Absci Corp (ABSI) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial Challenges
In the first half of 2025, the company plans to present efficacy data on ABS-301 with similar R&D expenses to ABS-101. They are using the same manufacturer, WuXi, for ABS-201....
By Yahoo! Finance | 1 day ago -
Book Review: 'The Absinthe Forger,' by Evan Rail
Evan Rail's "The Absinthe Forger" delves into the history of absinthe, exploring its allure and controversies. The book uncovers a fascinating world of collectors, forgers, and enthusiasts, shedding l...
By The New York Times | 3 weeks ago -
Absci Corporation (ABSI): A Penny Stock That Will Make You a Millionaire
A list of promising penny stocks includes Absci Corporation, a biotech company using AI for drug development. With 17 hedge funds holding stakes, ABSI shows potential for growth despite the slow natur...
By Yahoo! Finance | 2 months ago
